231 related articles for article (PubMed ID: 22470233)
1. Immunity over inability: The spontaneous regression of cancer.
Jessy T
J Nat Sci Biol Med; 2011 Jan; 2(1):43-9. PubMed ID: 22470233
[TBL] [Abstract][Full Text] [Related]
2. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas.
McCarthy EF
Iowa Orthop J; 2006; 26():154-8. PubMed ID: 16789469
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous regression: a hidden treasure buried in time.
Hoption Cann SA; van Netten JP; van Netten C; Glover DW
Med Hypotheses; 2002 Feb; 58(2):115-9. PubMed ID: 11812185
[TBL] [Abstract][Full Text] [Related]
4. The role of innate immunity in spontaneous regression of cancer.
Thomas JA; Badini M
Indian J Cancer; 2011; 48(2):246-51. PubMed ID: 21768675
[TBL] [Abstract][Full Text] [Related]
5. Dr William Coley and tumour regression: a place in history or in the future.
Hoption Cann SA; van Netten JP; van Netten C
Postgrad Med J; 2003 Dec; 79(938):672-80. PubMed ID: 14707241
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions.
Kramer MG; Masner M; Ferreira FA; Hoffman RM
Front Microbiol; 2018; 9():16. PubMed ID: 29472896
[TBL] [Abstract][Full Text] [Related]
7. The Hospital for the Ruptured and Crippled: William Bradley Coley, third Surgeon-in-Chief 1925-1933.
Levine DB
HSS J; 2008 Feb; 4(1):1-9. PubMed ID: 18751855
[TBL] [Abstract][Full Text] [Related]
8. Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited.
Decker WK; Safdar A
Cytokine Growth Factor Rev; 2009 Aug; 20(4):271-81. PubMed ID: 19656718
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley's Toxin Revisited?
Choe A; Mutsaers A; Rodrigues G; Chin J; Leung S; Winquist E
Cureus; 2022 Dec; 14(12):e32505. PubMed ID: 36654621
[TBL] [Abstract][Full Text] [Related]
10. Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations.
Kienle GS
Glob Adv Health Med; 2012 Mar; 1(1):92-100. PubMed ID: 24278806
[TBL] [Abstract][Full Text] [Related]
11. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective.
Wiemann B; Starnes CO
Pharmacol Ther; 1994; 64(3):529-64. PubMed ID: 7724661
[TBL] [Abstract][Full Text] [Related]
12. Coley's Lessons Remembered: Augmenting Mistletoe Therapy.
Orange M; Reuter U; Hobohm U
Integr Cancer Ther; 2016 Dec; 15(4):502-511. PubMed ID: 27207233
[TBL] [Abstract][Full Text] [Related]
13. Engineering Opportunities in Cancer Immunotherapy: After Decades of Missteps and Delays, a Growing Immune-Oncology Market and Improved Cancer Treatment Outcomes Open New Prospects for Biomedical Engineers and Data Scientists.
Zaharoff DA
IEEE Pulse; 2018; 9(4):8-11. PubMed ID: 30028678
[TBL] [Abstract][Full Text] [Related]
14. The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.
Murakami T; Kiyuna T; Kawaguchi K; Igarashi K; Singh AS; Hiroshima Y; Zhang Y; Zhao M; Miyake K; Nelson SD; Dry SM; Li Y; DeLong JC; Lwin TM; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
Cell Cycle; 2017 Jun; 16(11):1046-1052. PubMed ID: 28296559
[TBL] [Abstract][Full Text] [Related]
15. A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study.
NAUTS HC; FOWLER GA; BOGATKO FH
Acta Med Scand Suppl; 1953; 276():1-103. PubMed ID: 13039964
[No Abstract] [Full Text] [Related]
16. CpG 7909: PF 3512676, PF-3512676.
Drugs R D; 2006; 7(5):312-6. PubMed ID: 16922592
[TBL] [Abstract][Full Text] [Related]
17. Pathogens and glioma: a history of unexpected discoveries ushering in novel therapy.
Shah AH; Jusué-Torres I; Ivan ME; Komotar RJ; Kasahara N
J Neurosurg; 2018 Apr; 128(4):1139-1146. PubMed ID: 28598280
[TBL] [Abstract][Full Text] [Related]
18. The response of urological tumours to immunotherapy.
Gkialas I; Kalantzis A; Lykourinas M
J BUON; 2005; 10(3):329-36. PubMed ID: 17357186
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatment.
Kucerova P; Cervinkova M
Anticancer Drugs; 2016 Apr; 27(4):269-77. PubMed ID: 26813865
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy: Breakthrough or "deja vu, all over again"?
Sell S
Tumour Biol; 2017 Jun; 39(6):1010428317707764. PubMed ID: 28639883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
